-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Nexien Biopharma, Inc. quarterly/annual Return On Equity history and growth rate from 2016 to 2024.
- Nexien Biopharma, Inc. Return On Equity for the quarter ending December 31, 2024 was 56.3 %, a 43.9% decline year-over-year.
- Nexien Biopharma, Inc. annual Return On Equity for 2024 was 74.1 %, a 56.8% decline from 2023.
- Nexien Biopharma, Inc. annual Return On Equity for 2023 was 171 %, a 80.6% decline from 2022.
- Nexien Biopharma, Inc. annual Return On Equity for 2022 was 884 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)